REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q1 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $198,000 | +26.1% | 7,483 | +17.4% | 0.00% | +50.0% |
Q2 2022 | $157,000 | -12.8% | 6,375 | +17.6% | 0.00% | 0.0% |
Q1 2022 | $180,000 | +7.1% | 5,423 | +5.5% | 0.00% | 0.0% |
Q4 2021 | $168,000 | -20.0% | 5,142 | +2.9% | 0.00% | 0.0% |
Q3 2021 | $210,000 | +8.8% | 4,999 | +0.9% | 0.00% | 0.0% |
Q2 2021 | $193,000 | +21.4% | 4,956 | +6.5% | 0.00% | 0.0% |
Q1 2021 | $159,000 | -6.5% | 4,654 | +23.9% | 0.00% | 0.0% |
Q4 2020 | $170,000 | +71.7% | 3,757 | +4.5% | 0.00% | +100.0% |
Q3 2020 | $99,000 | +73.7% | 3,594 | +131.9% | 0.00% | 0.0% |
Q2 2020 | $57,000 | +29.5% | 1,550 | +13.1% | 0.00% | 0.0% |
Q1 2020 | $44,000 | 0.0% | 1,371 | +27.3% | 0.00% | 0.0% |
Q4 2019 | $44,000 | +7.3% | 1,077 | -6.7% | 0.00% | 0.0% |
Q3 2019 | $41,000 | -28.1% | 1,154 | +3.8% | 0.00% | 0.0% |
Q2 2019 | $57,000 | +14.0% | 1,112 | +26.2% | 0.00% | 0.0% |
Q1 2019 | $50,000 | +61.3% | 881 | +20.0% | 0.00% | 0.0% |
Q4 2018 | $31,000 | -26.2% | 734 | +31.3% | 0.00% | 0.0% |
Q3 2018 | $42,000 | +500.0% | 559 | +464.6% | 0.00% | – |
Q2 2018 | $7,000 | – | 99 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |